Nobivac Respira Bb Injection for dogs 10 doses

For active immunisation of dogs against Bordetella bronchiseptica to reduce clinical signs of upper respiratory tract disease and bacterial shedding post infection.
Onset of immunity: 2 weeks.
Duration of immunity: 7 months after primary vaccination.
1 year after re-vaccination.

Each dose of 1 ml contains:
Active substance:
Bordetella bronchiseptica fimbriae1: 88 - 399 U2
1 Purified from strain Bb7 92932
2 Antigenic mass ELISA units
Adjuvant:
dl-a-tocopheryl acetate: 74.7 mg
Excipient:
Thiomersal: 0.15 mg

Adverse reactions
A transient swelling at the site of injection (= 2 cm), which can occasionally be firm, may very commonly be present for up to 25 days post-vaccination. A medium size transient swelling at the site of injection (= 3.5 cm) may occur in common cases and can be painful. The swelling may uncommonly last for up to 35 days post-vaccination.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Use during pregnancy or lactation
Can be used during pregnancy. The safety of this vaccine has not been investigated during the first 20 days of gestation.